EDAP TMS S.A. Announces Exclusive Distribution of New Muscle Trainer Device in Japan Lyon, France, January 30, 2007 - EDAP TMS S.A. (Nasdaq: EDAP ), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development,
EDAP Sonolith Vision Achieves Top Outcomes in Stone Free Rates An October 2006 publication in the Journal of Endourology compared lithotripsy outcomes for the EDAP Sonolith Vision against the Dornier Compact Delta and the Dornier HM-3, widely considered the Gold Standard in lithotripsy outcomes.
EDAP TMS S.A. to Participate in International Urology Conferences LYON, France -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, today announces it is actively participating in the Societe Internationale d'Urologie (SIU)